Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00860470 · ClinicalTrials.gov registry record · Phase 3
Antenatal Micronutrient Supplementation and Infant Survival
A Phase 3 study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- Phase 3
- Development phase
- 44,567
- Enrollment target
NCT00860470 is a Phase 3 study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 44,567 participants.
The verdict
NCT00860470, a Phase 3 study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 44,567 participants
- Enrollment target
Study Summary
The purpose of this community-based randomized trial is to examine whether a daily antenatal and postnatal multiple micronutrient supplement given to women will enhance newborn and infant survival and health and other birth outcomes in a rural setting in northwestern Bangladesh.
Interventions
- DIETARY_SUPPLEMENT Iron (27 mg) - folic acid (600 ug)
- DIETARY_SUPPLEMENT Multiple micronutrient
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44,567 participants |
| Start Date | 2008-01 |
| Est. Completion | 2012-09 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00860470
The ClinicalTrials.gov registry entry for NCT00860470 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 44,567 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Iron (27 mg) - folic acid (600 ug) is the first listed.
NCT00860470 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00860470 about?
NCT00860470 is a clinical study titled "Antenatal Micronutrient Supplementation and Infant Survival". The purpose of this community-based randomized trial is to examine whether a daily antenatal and postnatal multiple micronutrient supplement given to women will enhance newborn and infant survival and health and other birth outcomes in a rural setting in northwestern Bangladesh.
What is the current status of trial NCT00860470?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 44,567 participants. The study started on 2008-01. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00860470?
The interventions under investigation include: Iron (27 mg) - folic acid (600 ug) (DIETARY_SUPPLEMENT), Multiple micronutrient (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00860470?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.